Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study.
Mireille Mpoudi-EtameTamara Tovar SanchezMarwân-Al-Qays BousmahPierrette Omgba BassegaJustin OlingaEric MimbeMichel FoalemCamille ChiepSerge EdimoMarie VarloteauxRaphaël PelloquinNadine LamareSylvie BoyerMartine PeetersJacques ReynesAlexandra CalmyAndrew HillEric DelaporteCharles Kouanfacknull nullPublished in: Open forum infectious diseases (2023)
NCT02777229.